A pooled internal standard, consisting of 25 μg of protein of each replicate was labelled with Cy2. Experimental samples were combined along with the pooled internal standard, 4.5 μL of 1% immobilized pH gradient (IPG) buffer (GE Healthcare), 5.4 μL of DeStreak Reagent (GE Healthcare), and rehydration buffer (7M Urea, 2M Thiourea, 4% CHAPS, 0.002% Bromophenol blue). Samples were then loaded onto 24 cm pH 3-11 non-linear Immobiline DryStrips (GE Healthcare). Active rehydration and isoelectric focusing (IEF) were performed using the Ettan IPGphor IEF system (GE Healthcare). Immediately following IEF, the IPG strips were equilibrated in equilibration buffer (100 mM Tris, 6M Urea, 30% Glycerol, 2% SDS, 0.002% Bromophenol blue), first in buffer containing 5 mg/mL DTT, then in equilibration containing 45mg/mL iodoacetamide. IPG strips were loaded onto 12.5% SDS-PAGE gels and sealed in place using 1% agarose.
Tissue microarrays (TMAs) immunohistochemistry
Tissue sections of 4µm from TMAs were deparaffinized, rehydrated and incubated in a methanol/0.3% H2O2 solution. Immunostaining for phosphorylated Akt was performed as in mice tissues (below). Immunostaining for PRR, SPON-2, and CST3 was performed using a XT autostainer (Ventana Medical System Inc.). Antigen retrieval was obtained using Cell Conditioning 1 (Ventana Medical System Inc.) for 60min. Antibody dilutions (PRR: Genetex, 1: 100; SPON-2: R&D System, 1:500; CST3: R&D System, 1:500) were manually added to the slides and incubated at 37° C for 60 minutes. Reactions for PRR were developed using the UltraView universal DAB detection kit (Ventana Medical System Inc.). For SPON-2 and CST3 IHCs, however, prediluted anti-goat secondary antibody (Santa-Cruz) was automatically dispensed and reactions were developed using the iView DAB detection kit without secondary antibody (Ventana Medical System Inc.) . Counterstaining was performed with Hematoxylin and bluing reagent (Ventana Medical System Inc.). All sections were scanned using a VS-110 microscope with a 20× 0,75NA objective and a resolution of 0,3225 µm (Olympus). Images were analyzed with the OlyVIA software (Olympus). The intensity of staining in epithelial cells was assessed based on the following scale: negative or very weak (0), weak (1+), intermediate (2+) and elevated (3+). Final values for each core were calculated as the average of the scores determined by two independent blinded scorers.
Immunohistochemistry (IHC) of mouse prostates
Four-micrometer sections were used for H&E staining and IHC. For IHC, slides were heated for 20 minutes at 60˚C, deparaffinized in xylenes and rehydrated in ethanol gradient. Antigen retrieval was performed using sodium citrate pH 6.0 (p-AKT) or EDTA pH 8.0 (PRR) buffer in a pressure cooker (Cuisinart). Endogenous peroxidase was deactivated with 3% H 2 O 2 , and slides were blocked using a protein blocking reagent (Dako) at room temperature. Tissue sections were incubated with primary antibodies overnight at 4° C (PRR: Gene Tex, 1:50 000; p-AKT: Cell signaling, 1:50) and then with their respective biotin-conjugated secondary antibodies (Santa-Cruz). Staining was developed using DAB (Sigma-Aldrich) containing 0.015% H 2 O 2 . Counterstaining was performed with hematoxylin.
Lysotracker image processing
Using a Zeiss microscope with 20X objective and an AxioCam HR camera, four to six images were taken from each well. Image J software was used to process the images. Cells on the bright-field images were manually counted using the Image J cell counter plugin. The mean gray value of images was then measured using the same software. Mean gray values were added and divided by the total number of cells counted from the corresponding bright-field images to find the mean gray value per cell.
Tumor tissue sample preparation
The dissected tissues were frozen at -20° C with OCT compound (Tissue-Tek; Miles Scientific), and 5-µm slices were cut and immediately fixed in formalin to perform H&E staining for pathological examination. Tumor zones were delimitated together with the adjacent non-cancerous tissues by a clinical pathologist, and further dissections were performed accordingly on the frozen tissues to isolate tumor regions. To prepare tissue lysates, frozen tissues were washed with nano-pure RNase-free water (Wisent) to remove all apparent traces of OCT compound. The tissues were then finely grinded in liquid nitrogen and lysed in RIPA buffer (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton-X-100 and 1% NP40) with freshly added protease inhibitors (Complete Mini, Roche). Samples were incubated for 20 minutes on ice and vortexed every 10 minutes before being clarified by centrifugation (17,000 × g, 4° C, 30 minutes). Protein concentrations were determined using the Bicinchoninic Acid assay (Pierce).
TCGA prostate cancer mRNA levels.
To evaluate the clinical relevance between PRR/ ATP6AP2 gene expression and clinical Gleason score, we included the annotated TCGA samples Gleason-6 (n = 49), Gleason-7 (n = 276), Gleason-8 (n = 63), Gleason-9 (n = 129) and Gleason-10 (n = 3) but excluded samples Gleason-N/A (n = 28). Mean Centered PRR/ATP6AP2 log2 transformed data were filtered based on log2 ratio differences greater than 2. Significance was determined by Wilcoxon rank T-test (P < 0.05). 
